论文部分内容阅读
Platinum diam(m)ine anticancer complexes, such as cisplatin, are successful in clinic,but suffer from problems of resistance and side-effects.Photoactivatable PtⅣ prodrugs offer the potential of targeted drug release and new mechanisms of action.